Gonadotropin-Releasing Hormone Receptor Signaling and Functions 2.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 13122
Special Issue Editor
Interests: signal transduction; GnRH receptor; gonadotropins; pituitary; gonadotropes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue is the continuation of our previous Special Issue “Gonadotropin-Releasing Hormone Receptor Signaling and Functions”.
GnRH is the primary hormone which controls the reproductive system in all vertebrates. GnRH binds to its cognate receptor (GnRHR) in pituitary gonadotropes to regulate the synthesis and secretion of the gonadotropins: Luteinizing Hormone (LH) and Follicle Stimulating Hormone (FSH). LH and FSH in turn control gametogenesis and sex hormone production in the gonads. GnRHR signaling is complex and involves interactions with G-proteins: in particular Gq, elevation of cytosolic Ca2+, and activation of selective Protein Kinase C (PKC) isoforms followed by activation of Mitogen activated protein kinase (MAPK) members such as ERK1/2, JNK and p38, culminating in gonadotropin secretion and synthesis. Identification of GnRHR signaling networks is a great challenge in the field. GnRHRs are present not only in pituitary gonadotropes, but also in some sex-hormone dependent cancers, including prostate cancer. Prostate cancer, which is also known as carcinoma of the prostate (CaP), is the second highest death-causing cancer in the western world. While GnRH secretion in a pulsatile manner regulates normal reproductive functions, application of GnRH agonists (GnRH-A), or antagonists in a continuous manner, disrupts this regulation. As a result, the continuous application of GnRH-A causes desensitization of the GnRHR in the pituitary, and termination of production and secretion of LH and FSH which in turn causes reduction in testosterone secretion, known as "Chemical Castration." This is the basis for the clinical use of GnRH analogs in prostate cancer. However, in later stages, CaP may become hormone-independent, therefore, treatment with GnRH-A in a continuous manner is not beneficial for these cancers. Hence, a novel potential treatment for hormone-independent CaP is required. Indeed, direct apoptotic effects of GnRH-A upon hormone-independent CaP cells (DU-145) has been described, but the magnitude of the effect was not sufficient. Since there is no cure to advanced hormone resistant CaP, new vistas for the development of a therapy is required.
Prof. Zvi Naor
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Gonadotropin Releasing Hormone (GnRH)
- GnRH Receptor
- Pituitary cells
- Gonadotropes
- Prostate cancer
- G proteins interactions
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.